Otonomy, Inc Alternatives & Competitors
12 companies similar to Otonomy, Inc
Companies similar to Otonomy, Inc
Santaris Pharma
Pioneering RNA-targeted therapies with rapid LNA-based drug development for diverse diseas...
Polaryx Therapeutics
Clinical-stage biotech developing patient-friendly drug candidates for the treatment of ly...
Paramus, United States
Newron Pharmaceuticals SpA
The Specialist in CNS Drug Development
Bresso, Italy
Atlantic Healthcare
Innovating therapeutic solutions for gastrointestinal diseases and unmet patient needs wor...
Rival Readout
Competing with Otonomy, Inc? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Marinomed Biotech AG
Innovative therapies and unique solutions - an ocean of ideas
Korneuburg, Austria
Chase Pharmaceuticals
Pioneering advancements in neuropsychiatric treatment for a brighter future
Asceneuron SA
Targeting the root cause of neurodegeneration
Lausanne, Switzerland
Benitec Biopharma Inc.
Silencing genes for life
Hayward, United States
Akebia Therapeutics
We're focused on the development & commercialization of therapeutics for people living wit...
Cambridge, United States
GENFIT
Dedicated to improving the lives of patients with liver diseases characterized by high unm...
Loos, France
Edgewise Therapeutics
On a mission to improve the lives of people facing serious muscle disease.
Boulder, United States
Ception Therapeutics, Inc.
Ception Therapeutics, Inc. is a biotechnology company based out of Malvern, Pennsylvania
Malvern, United States
About Otonomy, Inc
Otonomy, Inc is a biopharmaceutical company based in the United States that focuses on developing innovative therapeutics for diseases and disorders of the ear. Founded in 2008, Otonomy uses pioneering drug delivery technology to create products that provide sustained drug exposure from a single local administration. T...
Biopharmaceutical, Drug Delivery Technology, Ear Disorders, Innovative Therapeutics, Sustained Drug Exposure, Patent Estate, Ménière’s Disease, Hearing Loss, Tinnitus, Medical Research, Innovation, Pharmaceutical Development, Ear Health
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Otonomy, Inc: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Otonomy, Inc on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
